stem cell therapy for Parkinson disease’s disease is the second most common neurodegenerative disease in the United States. According to the National Institute of Neurological Disorders and Stroke, 500,000 Americans have a Parkinson’s disease diagnosis. Receiving this diagnosis can leave you unsure of what to expect or what steps to take. Learn more about what to…
For several decades, there has been extensive research into how regenerative medicine, also known as regenerative medicine, can help patients suffering from central nervous system disorders. One of the most heavily researched conditions has been stem cell therapy for Parkinson disease’s disease. Patients who struggle with Parkinson’s understand how severe their symptoms can be and how…
Treating the neurodegenerative disorder Parkinson’s disease can be incredibly challenging. Since the condition’s progression varies widely, there is no standard treatment. Ideally, patients work with their healthcare provider to create a treatment plan tailored to their symptoms. Here we will discuss the current treatments for stem cell therapy for Parkinson disease's Disease. Most treatment plans include…
Research has shown neuroinflammation to have a significant role in the pathogenesis of Parkinson’s disease (PD). Much of this same research has also demonstrated mesenchymal stem cells (MSCs), and specifically, allogeneic bone marrow-derived MSCs, can be effectively used as an immunomodulatory therapy for the potential treatment of PD. The goal of Schiess et al.’s study…
Regenerative medicine, also known as regenerative medicine, is emerging as a viable treatment for Parkinson’s disease as clinical trials move through the FDA approval process. Patients in clinical trials see positive results from mesenchymal regenerative medicine for Parkinson's Disease. What Is Parkinson’s Disease? Parkinson’s disease is a progressive, neurodegenerative condition. It occurs when dopamine-producing brain…
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder that currently affects nearly 6 million people worldwide and is currently the second most common neurological condition, behind only Alzheimer’s. Although the exact cause of PD remains unclear, the condition is characterized by the gradual loss of nerve cells in the brain responsible for producing the neurotransmitter…
Receiving a diagnosis of any chronic condition can be overwhelming, and stem cell therapy for Parkinson disease’s disease (PD) is certainly no exception. While it’s normal to feel a range of emotions after you’re first diagnosed, you might also feel a sense of relief to have a concrete diagnosis. And, with an accurate diagnosis, you…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!